Onconova Therapeutic
ONTX
Delayed Nasdaq - 02/16 09:59:52 pm
1.07USD
+0.94%
Upcoming events
03/02/18
American Association for Cancer Research Special Conference
03/26/18
FY 2017 Earnings Release (Projected)
05/14/18
Q1 2018 Earnings Release (Projected)
08/15/18
Interim 2018 Earnings Release (Projected)
Past Events
01/17/18 | 02:30pmBusiness Update Call
12/11/17 | 12:00pmAmerican Society of Hematology Meeting - Abstract 4235
12/09/17 | 11:30pmAmerican Society of Hematology Meeting - Abstract 1689
12/07/17 | 06:00pmLD Micro Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
5,55
6,37
-13%

0,86
Operating income (EBITDA)
Million $
Released
Forecast
Spread



-26,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-23,7
-22,7
-4,6%

-26,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-19,7
-19,7
0,01%

-24,8
Net income
Million $
Released
Forecast
Spread
-19,7
-19,7
-0,07%

-24,8
EPS
 $
Released
Forecast
Spread
-4,44
-0,59
-651%

-2,82
Announcement Date03/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
0,11
0,15
-27%

0,22
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-6,74
-6,30
-6,9%

-6,50
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-6,76
-6,49
-4,2%

-6,75
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-6,96
-6,28
-11%

-6,94
Net income
Million $
Released
Forecast
Spread
-6,96
-6,28
-11%

-6,94
EPS
 $
Released
Forecast
Spread
-0,71
-0,68
-4,4%

-0,68
Announcement Date11/09/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise